PharmaCyte Biotech (PMCB) FCF Margin (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly FCF Margin of 1343.92% for Q4 2012, down 108405.0% year-over-year from N/an in Q4 2011, and down 4.29% quarter-over-quarter from 1288.68% in Q3 2012.
PharmaCyte Biotech (PMCB) FCF Margin (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported FCF Margin for 3 consecutive years, with 1343.92% the latest figure, recorded in Q4 2012.
- In Q4 2012, FCF Margin fell 108405.0% year-over-year to 1343.92%; the TTM figure through Jul 2013 stood at 7391.63% (down 697037.0% YoY), while the FY2013 annual figure was 3210.74%, down 282117.0% from the prior year.
- FCF Margin eased to 1343.92% in Q4 2012 per PMCB's latest filing, from 1288.68% in the prior quarter.
- Across five years, FCF Margin topped out at 8.04% in Q4 2010 and bottomed at 1343.92% in Q4 2012.
- Historically, FCF Margin has averaged 500.32% across 3 years, with a median of 268.63% in 2011.
- On a YoY basis, FCF Margin climbed as much as 3694 bps in 2012 and fell as far as 108405 bps in 2012.
- PharmaCyte Biotech's FCF Margin stood at 8.04% in 2010, then sank by 3132 bps to 259.87% in 2011, then sank by 417 bps to 1343.92% in 2012.
- Business Quant data shows PMCB's FCF Margin at 1343.92% in Q4 2012, 1288.68% in Q3 2012, and 777.65% in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | PharmaCyte Biotech | 4.30 Mn | 4.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -1,343.92% |
| Jul 31, 2012 | -1,288.68% |
| Apr 30, 2012 | -777.65% |
| Jan 31, 2012 | -178.28% |
| Oct 31, 2011 | -259.87% |
| Jul 31, 2011 | -605.34% |
| Apr 30, 2011 | -277.38% |
| Jan 31, 2011 | -215.21% |
| Oct 31, 2010 | -8.04% |
| Jul 31, 2010 | -48.85% |